GoAI
Get started
Covista Inc. logo

Covista Inc.

CVSA

NYSEConsumer DefensiveEducation & Training Services

Open in GoAI

Previous close

$132.35

+$4.31 · +3.37%

Aug 21, 4:00 PM ET

Pre-market

$131.46

−$0.89 · -0.67%

Aug 24, 7:54 AM ET

CVSA company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

90

Deep Value

Momentum

57

Neutral

Sentiment

57

Mixed

Risk resilience

65

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Adtalem Global Education, Inc. is an enterprise dedicated to providing higher education. The company organizes its operations into three primary divisions: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment delivers various degree and non-degree offerings within the nursing and broader health professions higher education sector. Through its Walden segment, the company offers extensive online learning options, including certificates, bachelor's, master's, and doctoral degrees in a wide range of subjects such as nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. The Medical and Veterinary division provides both degree-granting and non-degree curricula tailored for post-secondary education in medicine and veterinary sciences. Dennis J. Keller and Ronald L. Taylor established the company in 1973, and its corporate headquarters are situated in Chicago, Illinois.

Industry
Education & Training Services
Sector
Consumer Defensive
Headquarters
US
CEO
Stephen W. Beard
Listed since
Feb 25, 2026
Employees
4,754

Market position

Day range

Current $132.35

52-week range

Current $132.35

Open
$128.25
Previous close
$128.04
Volume
343.02K
1.03× average
Average volume
333.27K
Average daily volume
Market cap
4.5B USD
Beta
0.62
Market reference 1
50-day average
$125.75
+5.25% above average
200-day average
$112.7
+17.44% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
4.87B USD
P/E (TTM)
17.53×
P/B (TTM)
3.11×
P/S (TTM)
2.3×
EV / EBITDA
10.42×
Earnings yield
5.76%
Free cash flow yield
8.99%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
57.34%
Operating margin
19.72%
Net margin
12.87%
Return on equity
17.40%
Return on assets
8.35%
Return on invested capital
12.29%

Financial health

Debt / equity
0.63×
Current ratio
1.09×
Altman Z-score
4.23
Piotroski F-score
8 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends64%37%9%-19%Gross margin, FY2022: 47.18%Gross margin, FY2023: 53.36%Gross margin, FY2024: 55.92%Gross margin, FY2025: 56.86%Gross margin, FY2026: 57.34%Operating margin, FY2022: 11.26%Operating margin, FY2023: 15.60%Operating margin, FY2024: 13.70%Operating margin, FY2025: 19.10%Operating margin, FY2026: 19.94%Net margin, FY2022: -11.76%Net margin, FY2023: 6.68%Net margin, FY2024: 8.63%Net margin, FY2025: 13.01%Net margin, FY2026: 12.87%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 47.18%. Gross margin FY2023 53.36%. Gross margin FY2024 55.92%. Gross margin FY2025 56.86%. Gross margin FY2026 57.34%. Operating margin FY2022 11.26%. Operating margin FY2023 15.60%. Operating margin FY2024 13.70%. Operating margin FY2025 19.10%. Operating margin FY2026 19.94%. Net margin FY2022 -11.76%. Net margin FY2023 6.68%. Net margin FY2024 8.63%. Net margin FY2025 13.01%. Net margin FY2026 12.87%.

Income trends

Revenue

1.95B USD+9.27%

Operating income

389.71M USD+14.10%

Net income

251.57M USD+8.12%
Income trends across reported periods2.17B USD1.32B USD472.48M USD−374.15M USDRevenue, FY2022: 1.38B USDRevenue, FY2023: 1.45B USDRevenue, FY2024: 1.58B USDRevenue, FY2025: 1.79B USDRevenue, FY2026: 1.95B USDOperating income, FY2022: 155.57M USDOperating income, FY2023: 226.33M USDOperating income, FY2024: 217.05M USDOperating income, FY2025: 341.54M USDOperating income, FY2026: 389.71M USDNet income, FY2022: −162.49M USDNet income, FY2023: 96.93M USDNet income, FY2024: 136.78M USDNet income, FY2025: 232.68M USDNet income, FY2026: 251.57M USDFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 1.38B USD. Revenue FY2023 1.45B USD. Revenue FY2024 1.58B USD. Revenue FY2025 1.79B USD. Revenue FY2026 1.95B USD. Operating income FY2022 155.57M USD. Operating income FY2023 226.33M USD. Operating income FY2024 217.05M USD. Operating income FY2025 341.54M USD. Operating income FY2026 389.71M USD. Net income FY2022 −162.49M USD. Net income FY2023 96.93M USD. Net income FY2024 136.78M USD. Net income FY2025 232.68M USD. Net income FY2026 251.57M USD.
Metric (USD)FY2026FY2025FY2024FY2023FY2022
Revenue1.95B USD1.79B USD1.58B USD1.45B USD1.38B USD
Cost of goods sold833.66M USD771.43M USD698.55M USD676.73M USD729.91M USD
Gross profit1.12B USD1.02B USD886.1M USD774.1M USD651.93M USD
Selling, general, and administrative730.72M USD671.11M USD614.47M USD576.01M USD566.49M USD
Operating expenses730.72M USD675.32M USD669.05M USD547.77M USD496.36M USD
Interest income5.46M USD8.22M USD9.18M USD10.65M USD3.82M USD
Interest expense39.16M USD52.32M USD63.66M USD63.17M USD98.94M USD
Depreciation and amortization83.02M USD84.47M USD75.32M USD151.09M USD186.6M USD
Operating income389.71M USD341.54M USD217.05M USD226.33M USD155.57M USD
Net income251.57M USD232.68M USD136.78M USD96.93M USD−162.49M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
90%
9 beats, 0 misses, 1 met estimate
Average EPS surprise
+15.06%
10 comparable reports
Latest EPS result
2.09
Estimate 1.89 · Beat by 10.58%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates2.532.111.691.27Q4 '24BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q4 2024, reported Dec 31, 2024: actual 1.98, estimate 1.37, surprise +44.53%, Beat. Q2 2025, reported May 8, 2025: actual 1.92, estimate 1.65, surprise +16.36%, Beat. Q3 2025, reported Aug 7, 2025: actual 1.66, estimate 1.53, surprise +8.50%, Beat. Q4 2025, reported Oct 30, 2025: actual 1.75, estimate 1.57, surprise +11.46%, Beat. Q1 2026, reported Jan 28, 2026: actual 2.43, estimate 2.19, surprise +10.96%, Beat. Q2 2026, reported May 7, 2026: actual 1.98, estimate 1.73, surprise +14.45%, Beat. Q3 2026, reported Aug 6, 2026: actual 2.09, estimate 1.89, surprise +10.58%, Beat. Q4 2026, reported Oct 29, 2026: actual —, estimate 1.84, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates523.52M485.38M447.24M409.1MQ4 '24BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q4 2024, reported Dec 31, 2024: actual 447.73M USD, estimate 429.24M USD, surprise +4.31%, Beat. Q2 2025, reported May 8, 2025: actual 466.06M USD, estimate 446.8M USD, surprise +4.31%, Beat. Q3 2025, reported Aug 7, 2025: actual 457.11M USD, estimate 440.93M USD, surprise +3.67%, Beat. Q4 2025, reported Oct 30, 2025: actual 462.29M USD, estimate 452.3M USD, surprise +2.21%, Beat. Q1 2026, reported Jan 28, 2026: actual 503.39M USD, estimate 488.72M USD, surprise +3.00%, Beat. Q2 2026, reported May 7, 2026: actual 487.03M USD, estimate 474.01M USD, surprise +2.75%, Beat. Q3 2026, reported Aug 6, 2026: actual 501.38M USD, estimate 486.6M USD, surprise +3.04%, Beat. Q4 2026, reported Oct 29, 2026: actual —, estimate 488.95M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$157.5

19.00% upside
Past 12 months12-month forecastHigh $175Average $157.5Low $140

Recent analyst actions

2 institutions
Truist SecuritiesmaintainBuy

CVSA news

zacks.com

Here's Why Covista (CVSA) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Read source
seekingalpha.com

Covista: Strong Secular Growth And Operating Leverage

Covista is rated BUY, driven by secular healthcare education demand and 12 consecutive quarters of enrollment growth. CVSA's Q4 saw revenue up 9.7% and adjusted EPS up 25.9%, with all segments showing positive operating…

Read source
fool.com

Covista SVP Sells 4,526 Shares for $615,000

The disposition of 4,526 shares on August 7, 2026, realized a total value of ~$615,000. The transaction resulted in a 14% reduction in the insider's direct equity holdings.

Read source
zacks.com

Why Covista (CVSA) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Read source
zacks.com

Covista Q4 Earnings & Revenues Top Estimates, Enrollments Up Y/Y

CVSA posts double-digit profit growth, record Walden enrollment and raises fiscal 2027 targets as strong execution continued across all three segments.

Read source
seekingalpha.com

Covista Inc. (CVSA) Q4 2026 Earnings Call Transcript

Covista Inc. (CVSA) Q4 2026 Earnings Call Transcript

Read source

CVSA peers

The Coca-Cola Company logo

KO

The Coca-Cola Company

$91.10

+0.66%

The Procter & Gamble Company logo

PG

The Procter & Gamble Company

$144.68

+1.20%

Philip Morris International Inc. logo

PM

Philip Morris International Inc.

$188.23

-1.72%

Anheuser-Busch InBev SA/NV logo

BUD

Anheuser-Busch InBev SA/NV

$78.92

+1.28%

Unilever PLC logo

UL

Unilever PLC

$64.14

+1.17%

British American Tobacco p.l.c. logo

BTI

British American Tobacco p.l.c.

$56.21

-0.86%

ETFs holding CVSA

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core S&P Small-Cap ETF logoiShares Core S&P Small-Cap ETFIJR
Market value
274.1M
Weight
0.24%
AUM
111.19B USD
Expense ratio
0.06%
Price / 1D
$147.31+0.64%
Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
128.4M
Weight
0.01%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
112.66M
Weight
0.14%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$299.96+0.77%
Vanguard Morningstar Small-Cap ETF logoVanguard Morningstar Small-Cap ETFVB
Market value
92.8M
Weight
0.05%
AUM
183.4B USD
Expense ratio
0.03%
Price / 1D
$304.76+0.64%
Vanguard Morningstar Small-Cap Value ETF logoVanguard Morningstar Small-Cap Value ETFVBR
Market value
58.93M
Weight
0.09%
AUM
68.3B USD
Expense ratio
0.05%
Price / 1D
$249.18+0.68%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
48.91M
Weight
0.05%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
iShares S&P Small-Cap 600 Growth ETF logoiShares S&P Small-Cap 600 Growth ETFIJT
Market value
41.67M
Weight
0.50%
AUM
8.22B USD
Expense ratio
0.18%
Price / 1D
$173.9+0.61%
iShares Russell 2000 Growth ETF logoiShares Russell 2000 Growth ETFIWO
Market value
41.05M
Weight
0.27%
AUM
15.16B USD
Expense ratio
0.24%
Price / 1D
$387.37+1.24%

Continue in GoAI

Research CVSA

research.disclaimer